Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Herman Waldmann
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Living Beings
Physiology
Anatomy
Procedures
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
85
Cobbold, Stephen
66
Hale, Geoff
29
Fairchild, Paul
23
Calne, Roy
23
Adams, Elizabeth
22
Tone, Masahide
22
Graca, Luis
18
Nolan, Kathleen
17
Rebello, Peppy
15
Friend, Peter
14
Tone, Yukiko
14
Thiru, Sathia
11
Metcalfe, Su
8
Novitzky, Nicolas
8
Wing, Mark
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Herman Waldmann (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Howie Duncan; Nolan Kathleen F; Daley Stephen; Butterfield Emma; Adams Elizabeth; Garcia-Rueda Hugo; Thompson Claire; Saunders Nigel J; Cobbold Stephen P; Tone Yukiko; Tone Masahide; Waldmann Herman
MS4A4B is a GITR-associated membrane adapter, expressed by regulatory T cells, which modulates T cell activation.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(7):4197-204.
-
2009: Cobbold Stephen P; Adams Elizabeth; Farquhar Claire A; Nolan Kathleen F; Howie Duncan; Lui Kathy O; Fairchild Paul J; Mellor Andrew L; Ron David; Waldmann Herman
Infectious tolerance via the consumption of essential amino acids and mTOR signaling.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(29):12055-60.
-
2009: Waldmann Herman; Cobbold Stephen
Regulatory T cells: context matters.
Immunity 2009;30(5):613-5.
-
2009: Clatworthy Menna R; Friend Peter J; Calne Roy Y; Rebello Perpetua R U; Hale Geoffrey; Waldmann Herman; Watson Christopher J E
Alemtuzumab (CAMPATH-1H) for the treatment of acute rejection in kidney transplant recipients: long-term follow-up.
Transplantation 2009;87(7):1092-5.
-
2009: Lui Kathy O; Waldmann Herman; Fairchild Paul J
Embryonic stem cells: overcoming the immunological barriers to cell replacement therapy.
Current stem cell research & therapy 2009;4(1):70-80.
-
2008: Li Z; Benghiat F S; Charbonnier L Marie; Kubjak C; Rivas M N; Cobbold S P; Waldmann H; De Wilde V; Petein M; Schuind F; Goldman M; Le Moine A
CD8+ T-Cell depletion and rapamycin synergize with combined coreceptor/stimulation blockade to induce robust limb allograft tolerance in mice.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2008;8(12):2527-36.
-
2008: Daley S R; Cobbold S P; Waldmann H
Fc-disabled anti-mouse CD40L antibodies retain efficacy in promoting transplantation tolerance.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2008;8(11):2265-71.
-
2008: Waldmann Herman; Adams Elizabeth; Fairchild Paul; Cobbold Stephen
Regulation and privilege in transplantation tolerance.
Journal of clinical immunology 2008;28(6):716-25.
-
2008: Waldmann Herman
Tolerance can be infectious.
Nature immunology 2008;9(9):1001-3.
-
2008: Waldmann Herman; Adams Elizabeth; Cobbold Stephen
Reprogramming the immune system: co-receptor blockade as a paradigm for harnessing tolerance mechanisms.
Immunological reviews 2008;223():361-70.
-
2008: Zhou Zhaocai; Tone Yukiko; Song Xiaomin; Furuuchi Keiji; Lear James D; Waldmann Herman; Tone Masahide; Greene Mark I; Murali Ramachandran
Structural basis for ligand-mediated mouse GITR activation.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(2):641-5.
-
2008: Waldmann Herman
Special regulatory T cell review: The suppression problem!
Immunology 2008;123(1):11-2.
-
2007: Robertson Nathan J; Brook Frances A; Gardner Richard L; Cobbold Stephen P; Waldmann Herman; Fairchild Paul J
Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(52):20920-5.
-
2007: Fairchild Paul J; Robertson Nathan J; Minger Stephen L; Waldmann Herman
Embryonic stem cells: protecting pluripotency from alloreactivity.
Current opinion in immunology 2007;19(5):596-602.
-
2007: Daley Stephen R; Ma Jianbo; Adams Elizabeth; Cobbold Stephen P; Waldmann Herman
A key role for TGF-beta signaling to T cells in the long-term acceptance of allografts.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(6):3648-54.
-
2007: Yates Stephen F; Paterson Alison M; Nolan Kathleen F; Cobbold Stephen P; Saunders Nigel J; Waldmann Herman; Fairchild Paul J
Induction of regulatory T cells and dominant tolerance by dendritic cells incapable of full activation.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(2):967-76.
-
2007: Robertson Nathan J; Fairchild Paul J; Waldmann Herman
Ectopic transplantation of tissues under the kidney capsule.
Methods in molecular biology (Clifton, N.J.) 2007;380():347-53.
-
2007: Nolan Kathleen F; Cobbold Stephen P; Waldmann Herman
SAGE analysis of cell types involved in tolerance induction.
Methods in molecular biology (Clifton, N.J.) 2007;380():225-51.
-
2007: Fairchild Paul J; Nolan Kathleen F; Waldmann Herman
Genetic modification of dendritic cells through the directed differentiation of embryonic stem cells.
Methods in molecular biology (Clifton, N.J.) 2007;380():59-72.
-
2006: Cobbold Stephen P; Adams Elizabeth; Graca Luis; Daley Stephen; Yates Stephen; Paterson Alison; Robertson Nathan J; Nolan Kathleen F; Fairchild Paul J; Waldmann Herman
Immune privilege induced by regulatory T cells in transplantation tolerance.
Immunological reviews 2006;213():239-55.
-
2006: Waldmann Herman; Adams Elizabeth; Fairchild Paul; Cobbold Stephen
Infectious tolerance and the long-term acceptance of transplanted tissue.
Immunological reviews 2006;212():301-13.
-
2006: Glatting Gerhard; Müller Marguerite; Koop Bernd; Hohl Kathrin; Friesen Claudia; Neumaier Bernd; Berrie Eleanor; Bird Pru; Hale Geoffrey; Blumstein Norbert M; Waldmann Herman; Bunjes Donald; Reske Sven N
Anti-CD45 monoclonal antibody YAML568: A promising radioimmunoconjugate for targeted therapy of acute leukemia.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(8):1335-41.
-
2006: Waldmann Herman; Chen Tse-Ching; Graca Luis; Adams Elizabeth; Daley Stephen; Cobbold Stephen; Fairchild Paul J
Regulatory T cells in transplantation.
Seminars in immunology 2006;18(2):111-9.
-
2006: Coles Alasdair J; Cox Amanda; Le Page Emmanuelle; Jones Joanne; Trip S Anand; Deans Jackie; Seaman Shaun; Miller David H; Hale Geoff; Waldmann Herman; Compston D Alastair
The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy.
Journal of neurology 2006;253(1):98-108.
-
2006: Graca Luis; Waldmann Herman
Reprogramming the immune system using antibodies.
Methods in molecular biology (Clifton, N.J.) 2006;333():247-68.
-
2006: Graca Luis; Daley Stephen; Fairchild Paul J; Cobbold Stephen P; Waldmann Herman
Co-receptor and co-stimulation blockade for mixed chimerism and tolerance without myelosuppressive conditioning.
BMC immunology 2006;7():9.
-
2005: Paterson A M; Yates S F; Nolan K F; Waldmann H
The new immunosuppression: intervention at the dendritic cell-T-cell interface.
Current drug targets. Immune, endocrine and metabolic disorders 2005;5(4):397-411.
-
2005: Cox Amanda L; Thompson Sara A J; Jones Joanne L; Robertson Vicki H; Hale Geoff; Waldmann Herman; Compston D Alastair S; Coles Alasdair J
Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis.
European journal of immunology 2005;35(11):3332-42.
-
2005: Novitzky N; Thomas V; Hale G; Waldmann H
Myeloablative conditioning is well tolerated by older patients receiving T-cell-depleted grafts.
Bone marrow transplantation 2005;36(8):675-82.
-
2005: Waldmann Herman; Hale Geoff
CAMPATH: from concept to clinic.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 2005;360(1461):1707-11.
-
2005: Keymeulen Bart; Vandemeulebroucke Evy; Ziegler Anette G; Mathieu Chantal; Kaufman Leonard; Hale Geoff; Gorus Frans; Goldman Michel; Walter Markus; Candon Sophie; Schandene Liliane; Crenier Laurent; De Block Christophe; Seigneurin Jean-Marie; De Pauw Pieter; Pierard Denis; Weets Ilse; Rebello Peppy; Bird Pru; Berrie Eleanor; Frewin Mark; Waldmann Herman; Bach Jean-François; Pipeleers Daniel; Chatenoud Lucienne
Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.
The New England journal of medicine 2005;352(25):2598-608.
-
2005: Watson Christopher J E; Bradley J Andrew; Friend Peter J; Firth John; Taylor Craig J; Bradley John R; Smith Kenneth G C; Thiru Sathia; Jamieson Neville V; Hale Geoff; Waldmann Herman; Calne Roy
Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation--efficacy and safety at five years.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(6):1347-53.
-
2005: Benghiat Fleur Samantha; Graca Luis; Braun Michel Y; Detienne Sophie; Moore Fabrice; Buonocore Sofia; Flamand Véronique; Waldmann Herman; Goldman Michel; Le Moine Alain
Critical influence of natural regulatory CD25+ T cells on the fate of allografts in the absence of immunosuppression.
Transplantation 2005;79(6):648-54.
-
2005: Graca Luis; Chen Tse-Ching; Le Moine Alain; Cobbold Stephen P; Howie Duncan; Waldmann Herman
Dominant tolerance: activation thresholds for peripheral generation of regulatory T cells.
Trends in immunology 2005;26(3):130-5.
-
2005: Fairchild Paul J; Nolan Kathleen F; Cartland Siân; Waldmann Herman
Embryonic stem cells: a novel source of dendritic cells for clinical applications.
International immunopharmacology 2005;5(1):13-21.
-
2005: Fairchild Paul J; Robertson Nathan J; Cartland Siân; Nolan Kathleen F; Waldmann Herman
Cell replacement therapy and the evasion of destructive immunity.
Stem cell reviews 2005;1(2):159-67.
-
2005: Waldmann H; Graca L; Adams E; Fairchild P; Cobbold S
Regulatory T cells in transplantation tolerance.
Current topics in microbiology and immunology 2005;293():249-64.
-
2004: Winsor-Hines Dawn; Merrill Christopher; O'Mahony Mark; Rao Patricia E; Cobbold Stephen P; Waldmann Herman; Ringler Douglas J; Ponath Paul D
Induction of immunological tolerance/hyporesponsiveness in baboons with a nondepleting CD4 antibody.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(7):4715-23.
-
2004: Fairchild Paul J; Cartland Siân; Nolan Kathleen F; Waldmann Herman
Embryonic stem cells and the challenge of transplantation tolerance.
Trends in immunology 2004;25(9):465-70.
-
2004: Hale Geoff; Rebello Peppy; Brettman Lee R; Fegan Chris; Kennedy Ben; Kimby Eva; Leach Mike; Lundin Jeanette; Mellstedt Håkan; Moreton Paul; Rawstron Andy C; Waldmann Herman; Osterborg Anders; Hillmen Peter
Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration.
Blood 2004;104(4):948-55.
-
2004: Waldmann Herman; Cobbold Stephen
Exploiting tolerance processes in transplantation.
Science (New York, N.Y.) 2004;305(5681):209-12.
-
2004: Graca Luis; Le Moine Alain; Lin Chun-Yen; Fairchild Paul J; Cobbold Stephen P; Waldmann Herman
Donor-specific transplantation tolerance: the paradoxical behavior of CD4+CD25+ T cells.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(27):10122-6.
-
2004: Chen Tse-Ching; Waldmann Herman; Fairchild Paul J
Induction of dominant transplantation tolerance by an altered peptide ligand of the male antigen Dby.
The Journal of clinical investigation 2004;113(12):1754-62.
-
2004: Murphy Conor C; Greiner Kathrin; Plskova Jarka; Duncan Linda; Frost Andrew; Isaacs John D; Rebello Peppy; Waldmann Herman; Hale Geoff; Forrester John V; Dick Andrew D
Neutralizing tumor necrosis factor activity leads to remission in patients with refractory noninfectious posterior uveitis.
Archives of ophthalmology 2004;122(6):845-51.
-
2004: Cobbold Stephen P; Castejon Raquel; Adams Elizabeth; Zelenika Diana; Graca Luis; Humm Susan; Waldmann Herman
Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(10):6003-10.
-
2004: Chen Tse-Ching; Cobbold Stephen P; Fairchild Paul J; Waldmann Herman
Generation of anergic and regulatory T cells following prolonged exposure to a harmless antigen.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(10):5900-7.
-
2004: Waldmann Herman; Graca Luis; Cobbold Stephen; Adams Elizabeth; Tone Masahide; Tone Yuki
Regulatory T cells and organ transplantation.
Seminars in immunology 2004;16(2):119-26.
-
2004: Nolan Kathleen F; Strong Victoria; Soler Dulce; Fairchild Paul J; Cobbold Stephen P; Croxton Ruth; Gonzalo Jose-Angel; Rubio Ana; Wells Meghan; Waldmann Herman
IL-10-conditioned dendritic cells, decommissioned for recruitment of adaptive immunity, elicit innate inflammatory gene products in response to danger signals.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(4):2201-9.
-
2004: Novitzky N; Thomas V; Stubbings H; Hale G; Waldmann H
Radiotherapy-based conditioning is effective immunosuppression for patients undergoing transplantation with T-cell depleted stem cell grafts for severe aplasia.
Cytotherapy 2004;6(5):450-6.
-
2004: Novitzky N; Thomas V; Hale G; Waldmann H
Campath-1 Abs 'in the bag' for hematological malignancies: the Cape Town experience.
Cytotherapy 2004;6(2):172-81.
-
2003: Cobbold Stephen P; Nolan Kathleen F; Graca Luis; Castejon Raquel; Le Moine Alain; Frewin Mark; Humm Susan; Adams Elizabeth; Thompson Sara; Zelenika Diana; Paterson Alison; Yates Stephen; Fairchild Paul J; Waldmann Herman
Regulatory T cells and dendritic cells in transplantation tolerance: molecular markers and mechanisms.
Immunological reviews 2003;196():109-24.
-
2003: Tone Masahide; Tone Yukiko; Adams Elizabeth; Yates Stephen F; Frewin Mark R; Cobbold Stephen P; Waldmann Herman
Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(25):15059-64.
-
2003: Graca Luis; Le Moine Alain; Cobbold Stephen P; Waldmann Herman
Dominant transplantation tolerance. Opinion.
Current opinion in immunology 2003;15(5):499-506.
-
2003: Cobbold Stephen P; Adams Elizabeth; Graca Luis; Waldmann Herman
Serial analysis of gene expression provides new insights into regulatory T cells.
Seminars in immunology 2003;15(4):209-14.
-
2003: Waldmann Herman
The new immunosuppression.
Current opinion in chemical biology 2003;7(4):476-80.
-
2003: Fairchild Paul J; Nolan Kathleen F; Cartland Siân; Graça Luis; Waldmann Herman
Stable lines of genetically modified dendritic cells from mouse embryonic stem cells.
Transplantation 2003;76(3):606-8.
-
2003: Cobbold Stephen P; Graca Luis; Lin Chun-Yen; Adams Elizabeth; Waldmann Herman
Regulatory T cells in the induction and maintenance of peripheral transplantation tolerance.
Transplant international : official journal of the European Society for Organ Transplantation 2003;16(2):66-75.
-
2003: Graca Luis; Le Moine Alain; Cobbold Stephen P; Waldmann Herman
Antibody-induced transplantation tolerance: the role of dominant regulation.
Immunologic research 2003;28(3):181-91.
-
2003: Fairchild Paul J; Nolan Kathleen F; Waldmann Herman
Probing dendritic cell function by guiding the differentiation of embryonic stem cells.
Methods in enzymology 2003;365():169-86.
-
2002: Novitzky Nicolas; Davison Glenda M; Hale Geoffrey; Waldmann Herman
Immune reconstitution at 6 months following T-cell depleted hematopoietic stem cell transplantation is predictive for treatment outcome.
Transplantation 2002;74(11):1551-9.
-
2002: Hale G; Slavin S; Goldman J M; Mackinnon S; Giralt S; Waldmann H
Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?
Bone marrow transplantation 2002;30(12):797-804.
-
2002: Lin Chun-Yen; Graca Luis; Cobbold Stephen P; Waldmann Herman
Dominant transplantation tolerance impairs CD8+ T cell function but not expansion.
Nature immunology 2002;3(12):1208-13.
-
2002: Symons Julian A; Adams Elizabeth; Tscharke David C; Reading Patrick C; Waldmann Herman; Smith Geoffrey L
The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model.
The Journal of general virology 2002;83(Pt 11):2833-44.
-
2002: Lundin Jeanette; Kimby Eva; Björkholm Magnus; Broliden Per-Anders; Celsing Fredrik; Hjalmar Viktoria; Möllgård Lars; Rebello Peppy; Hale Geoff; Waldmann Herman; Mellstedt Håkan; Osterborg Anders
Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL).
Blood 2002;100(3):768-73.
-
2002: Waldmann Herman
Reprogramming the immune system.
Immunological reviews 2002;185():227-35.
-
2002: Graca Luis; Cobbold Stephen P; Waldmann Herman
Identification of regulatory T cells in tolerated allografts.
The Journal of experimental medicine 2002;195(12):1641-6.
-
2002: Graca Luis; Thompson Sara; Lin Chun-Yen; Adams Elizabeth; Cobbold Stephen P; Waldmann Herman
Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(11):5558-65.
-
2002: Tone Masahide; Tone Yukiko; Babik Jennifer M; Lin Chun-Yen; Waldmann Herman
The role of Sp1 and NF-kappa B in regulating CD40 gene expression.
The Journal of biological chemistry 2002;277(11):8890-7.
-
2002: Zelenika Diana; Adams Elizabeth; Humm Sue; Graca Luis; Thompson Sara; Cobbold Stephen P; Waldmann Herman
Regulatory T cells overexpress a subset of Th2 gene transcripts.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(3):1069-79.
-
2001: Waldmann H
Therapeutic approaches for transplantation.
Current opinion in immunology 2001;13(5):606-10.
-
2001: Waldmann H; Cobbold S
Approaching tolerance in transplantation.
International archives of allergy and immunology 2001;126(1):11-22.
-
2001: Zelenika D; Adams E; Humm S; Lin C Y; Waldmann H; Cobbold S P
The role of CD4+ T-cell subsets in determining transplantation rejection or tolerance.
Immunological reviews 2001;182():164-79.
-
2001: Waldmann H; Hale G; Cobbold S
Appropriate targets for monoclonal antibodies in the induction of transplantation tolerance.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 2001;356(1409):659-63.
-
2001: Waldmann H; Cobbold S
Regulating the immune response to transplants. a role for CD4+ regulatory cells?
Immunity 2001;14(4):399-406.
-
2001: Tone M; Tone Y; Fairchild P J; Wykes M; Waldmann H
Regulation of CD40 function by its isoforms generated through alternative splicing.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(4):1751-6.
-
2001: Hale G; Cobbold S; Novitzky N; Bunjes D; Willemze R; Prentice H G; Milligan D; MacKinnon S; Waldmann H;
CAMPATH-1 antibodies in stem-cell transplantation.
Cytotherapy 2001;3(3):145-64.
-
2000: Fairchild P J; Brook F A; Gardner R L; Graça L; Strong V; Tone Y; Tone M; Nolan K F; Waldmann H
Directed differentiation of dendritic cells from mouse embryonic stem cells.
Current biology : CB 2000;10(23):1515-8.
-
2000: Graca L; Honey K; Adams E; Cobbold S P; Waldmann H
Cutting edge: anti-CD154 therapeutic antibodies induce infectious transplantation tolerance.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(9):4783-6.
-
2000: Fairchild P J; Waldmann H
Dendritic cells and prospects for transplantation tolerance.
Current opinion in immunology 2000;12(5):528-35.
-
2000: Fairchild P J; Waldmann H
Extrathymic signals regulate the onset of T cell repertoire selection.
European journal of immunology 2000;30(7):1948-56.
-
2000: Hale G; Jacobs P; Wood L; Fibbe W E; Barge R; Novitzky N; Toit C; Abrahams L; Thomas V; Bunjes D; Duncker C; Wiesneth M; Selleslag D; Hidajat M; Starobinski M; Bird P; Waldmann H
CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells.
Bone marrow transplantation 2000;26(1):69-76.
-
2000: Powell M J; Thompson S A; Tone Y; Waldmann H; Tone M
Posttranscriptional regulation of IL-10 gene expression through sequences in the 3'-untranslated region.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(1):292-6.
-
2000: Tone M; Powell M J; Tone Y; Thompson S A; Waldmann H
IL-10 gene expression is controlled by the transcription factors Sp1 and Sp3.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(1):286-91.
-
2000: Honey K; Cobbold S P; Waldmann H
Dominant tolerance and linked suppression induced by therapeutic antibodies do not depend on Fas-FasL interactions.
Transplantation 2000;69(8):1683-9.
-
2000: Honey K; Bemelman F; Cobbold S P; Waldmann H
High dose bone marrow transplantation induces deletion of antigen-specific T cells in a Fas-independent manner.
Transplantation 2000;69(8):1676-82.
-
2000: Davison G M; Novitzky N; Kline A; Thomas V; Abrahams L; Hale G; Waldmann H
Immune reconstitution after allogeneic bone marrow transplantation depleted of T cells.
Transplantation 2000;69(7):1341-7.
-
2000: Calne R; Moffatt S D; Friend P J; Jamieson N V; Bradley J A; Hale G; Firth J; Bradley J; Smith K G; Waldmann H
Prope tolerance with induction using Campath 1H and low-dose cyclosporin monotherapy in 31 cadaveric renal allograft recipients.
Nippon Geka Gakkai zasshi 2000;101(3):301-6.
-
2000: Dick A D; Meyer P; James T; Forrester J V; Hale G; Waldmann H; Isaacs J D
Campath-1H therapy in refractory ocular inflammatory disease.
The British journal of ophthalmology 2000;84(1):107-9.
-
1999: Friend P J; Hale G; Chatenoud L; Rebello P; Bradley J; Thiru S; Phillips J M; Waldmann H
Phase I study of an engineered aglycosylated humanized CD3 antibody in renal transplant rejection.
Transplantation 1999;68(11):1632-7.
-
1999: Calne R; Moffatt S D; Friend P J; Jamieson N V; Bradley J A; Hale G; Firth J; Bradley J; Smith K G; Waldmann H
Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients.
Transplantation 1999;68(10):1613-6.
-
1999: Rebello P R; Hale G; Friend P J; Cobbold S P; Waldmann H
Anti-globulin responses to rat and humanized CAMPATH-1 monoclonal antibody used to treat transplant rejection.
Transplantation 1999;68(9):1417-20.
-
1999: Coles A J; Wing M; Smith S; Coraddu F; Greer S; Taylor C; Weetman A; Hale G; Chatterjee V K; Waldmann H; Compston A
Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis.
Lancet 1999;354(9191):1691-5.
-
1999: Honey K; Cobbold S P; Waldmann H
CD40 ligand blockade induces CD4+ T cell tolerance and linked suppression.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(9):4805-10.
-
1999: Lockwood C M; Elliott J D; Brettman L; Hale G; Rebello P; Frewin M; Ringler D; Merrill C; Waldmann H
Anti-adhesion molecule therapy as an interventional strategy for autoimmune inflammation.
Clinical immunology (Orlando, Fla.) 1999;93(2):93-106.
-
1999: Tone M; Nolan K F; Walsh L A; Tone Y; Thompson S A; Waldmann H
Structure and chromosomal location of mouse and human CD52 genes.
Biochimica et biophysica acta 1999;1446(3):334-40.
-
1999: Coles A J; Wing M G; Molyneux P; Paolillo A; Davie C M; Hale G; Miller D; Waldmann H; Compston A
Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis.
Annals of neurology 1999;46(3):296-304.
-
1999: Babik J M; Adams E; Tone Y; Fairchild P J; Tone M; Waldmann H
Expression of murine IL-12 is regulated by translational control of the p35 subunit.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(7):4069-78.
-
1999: Gilliland L K; Walsh L A; Frewin M R; Wise M P; Tone M; Hale G; Kioussis D; Waldmann H
Elimination of the immunogenicity of therapeutic antibodies.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(6):3663-71.
-
1999: Novitzky N; Thomas V; Hale G; Waldmann H
Ex vivo depletion of T cells from bone marrow grafts with CAMPATH-1 in acute leukemia: graft-versus-host disease and graft-versus-leukemia effect.
Transplantation 1999;67(4):620-6.
-
1999: Wise M; Zelenika D; Bemelman F; Latinne D; Bazin H; Cobbold S; Waldmann H
CD4 T cells can reject major histocompatibility complex class I-incompatible skin grafts.
European journal of immunology 1999;29(1):156-67.
-
1999: Tone M; Diamond L E; Walsh L A; Tone Y; Thompson S A; Shanahan E M; Logan J S; Waldmann H
High level transcription of the complement regulatory protein CD59 requires an enhancer located in intron 1.
The Journal of biological chemistry 1999;274(2):710-6.
-
1999: Honey K; Cobbold S P; Waldmann H
Dominant regulation: a common mechanism of monoclonal antibody induced tolerance?
Immunologic research 1999;20(1):1-14.
-
1998: Hale G; Zhang M J; Bunjes D; Prentice H G; Spence D; Horowitz M M; Barrett A J; Waldmann H
Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection.
Blood 1998;92(12):4581-90.
-
1998: Wise M P; Bemelman F; Cobbold S P; Waldmann H
Linked suppression of skin graft rejection can operate through indirect recognition.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(11):5813-6.
-
1998: Cobbold S; Waldmann H
Infectious tolerance.
Current opinion in immunology 1998;10(5):518-24.
-
1998: Isaacs J D; Greenwood J; Waldmann H
Therapy with monoclonal antibodies. II. The contribution of Fc gamma receptor binding and the influence of C(H)1 and C(H)3 domains on in vivo effector function.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(8):3862-9.
-
1998: Zelenika D; Adams E; Mellor A; Simpson E; Chandler P; Stockinger B; Waldmann H; Cobbold S P
Rejection of H-Y disparate skin grafts by monospecific CD4+ Th1 and Th2 cells: no requirement for CD8+ T cells or B cells.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(4):1868-74.
-
1998: Nolan K F; Greaves D R; Waldmann H
The human interleukin 18 gene IL18 maps to 11q22.2-q22.3, closely linked to the DRD2 gene locus and distinct from mapped IDDM loci.
Genomics 1998;51(1):161-3.
-
1998: Calne R; Friend P; Moffatt S; Bradley A; Hale G; Firth J; Bradley J; Smith K; Waldmann H
Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients.
Lancet 1998;351(9117):1701-2.
-
1998: Dick A D; Duncan L; Hale G; Waldmann H; Isaacs J
Neutralizing TNF-alpha activity modulates T-cell phenotype and function in experimental autoimmune uveoretinitis.
Journal of autoimmunity 1998;11(3):255-64.
-
1998: Hale G; Waldmann H
Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH Users.
Blood 1998;91(8):3079-83.
-
1998: Bemelman F; Honey K; Adams E; Cobbold S; Waldmann H
Bone marrow transplantation induces either clonal deletion or infectious tolerance depending on the dose.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(6):2645-8.
-
1998: Elliott J D; Lockwood C M; Hale G; Waldmann H
Semi-specific immuno-absorption and monoclonal antibody therapy in ANCA positive vasculitis: experience in four cases.
Autoimmunity 1998;28(3):163-71.
-
1998: Waldmann H; Bemelman F; Cobbold S
Tolerance induction with CD4 monoclonal antibodies.
Novartis Foundation symposium 1998;215():146-52; discussion 152-8, 186-90.
-
1998: Waldmann H; Cobbold S
How do monoclonal antibodies induce tolerance? A role for infectious tolerance?
Annual review of immunology 1998;16():619-44.
-
1997: Tone M; Thompson S A; Tone Y; Fairchild P J; Waldmann H
Regulation of IL-18 (IFN-gamma-inducing factor) gene expression.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(12):6156-63.
-
1997: Isaacs J D; Burrows N; Wing M; Keogan M T; Rebello P R; Watts R A; Pye R J; Norris P; Hazelman B L; Hale G; Waldmann H
Humanized anti-CD4 monoclonal antibody therapy of autoimmune and inflammatory disease.
Clinical and experimental immunology 1997;110(2):158-66.
-
1997: Scully R; Cobbold S P; Mellor A L; Wissing M; Arnold B; Waldmann H
A role for Th2 cytokines in the suppression of CD8+ T cell-mediated graft rejection.
European journal of immunology 1997;27(7):1663-70.
-
1997: Davies J D; Cobbold S P; Waldmann H
Strain variation in susceptibility to monoclonal antibody-induced transplantation tolerance.
Transplantation 1997;63(11):1570-3.
-
1996: Lockwood C M; Thiru S; Stewart S; Hale G; Isaacs J; Wraight P; Elliott J; Waldmann H
Treatment of refractory Wegener's granulomatosis with humanized monoclonal antibodies.
QJM : monthly journal of the Association of Physicians 1996;89(12):903-12.
-
1996: Wing M G; Moreau T; Greenwood J; Smith R M; Hale G; Isaacs J; Waldmann H; Lachmann P J; Compston A
Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells.
The Journal of clinical investigation 1996;98(12):2819-26.
-
1996: Isaacs J D; Wing M G; Greenwood J D; Hazleman B L; Hale G; Waldmann H
A therapeutic human IgG4 monoclonal antibody that depletes target cells in humans.
Clinical and experimental immunology 1996;106(3):427-33.
-
1996: Marshall S E; Cobbold S P; Davies J D; Martin G M; Phillips J M; Waldmann H
Tolerance and suppression in a primed immune system.
Transplantation 1996;62(11):1614-21.
-
1996: Chen Z K; Cobbold S P; Waldmann H; Metcalfe S
Amplification of natural regulatory immune mechanisms for transplantation tolerance.
Transplantation 1996;62(9):1200-6.
-
1996: Moreau T; Coles A; Wing M; Thorpe J; Miller D; Moseley I; Issacs J; Hale G; Clayton D; Scolding N; Waldmann H; Compston A
CAMPATH-IH in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 1996;1(6):357-65.
-
1996: Davies J D; Martin G; Phillips J; Marshall S E; Cobbold S P; Waldmann H
T cell regulation in adult transplantation tolerance.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(2):529-33.
-
1996: Tone Y; Thompson S A; Babik J M; Nolan K F; Tone M; Raven C; Waldmann H
Structure and chromosomal location of the mouse interleukin-12 p35 and p40 subunit genes.
European journal of immunology 1996;26(6):1222-7.
-
1996: Davies J D; Leong L Y; Mellor A; Cobbold S P; Waldmann H
T cell suppression in transplantation tolerance through linked recognition.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(10):3602-7.
-
1996: Hale G; Waldmann H
Recent results using CAMPATH-1 antibodies to control GVHD and graft rejection.
Bone marrow transplantation 1996;17(3):305-8.
-
1996: Cobbold S P; Adams E; Marshall S E; Davies J D; Waldmann H
Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8.
Immunological reviews 1996;149():5-33.
-
1996: Moreau T; Coles A; Wing M; Isaacs J; Hale G; Waldmann H; Compston A
Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis.
Brain : a journal of neurology 1996;119 ( Pt 1)():225-37.
-
1995: Diamond L E; McCurry K R; Oldham E R; Tone M; Waldmann H; Platt J L; Logan J S
Human CD59 expressed in transgenic mouse hearts inhibits the activation of complement.
Transplant immunology 1995;3(4):305-12.
-
1995: Brons I G; Davies H S; Watson C J; Cobbold S P; Waldmann H; Calne R Y
Substantial peripheral T-cell depletion before grafting is beneficial in islet transplantation.
Transplantation proceedings 1995;27(6):3181.
-
1995: Routledge E G; Falconer M E; Pope H; Lloyd I S; Waldmann H
The effect of aglycosylation on the immunogenicity of a humanized therapeutic CD3 monoclonal antibody.
Transplantation 1995;60(8):847-53.
-
1995: Wing M G; Waldmann H; Isaacs J; Compston D A; Hale G
Ex-vivo whole blood cultures for predicting cytokine-release syndrome: dependence on target antigen and antibody isotype.
Therapeutic immunology 1995;2(4):183-90.
-
1995: Kooyman D L; Byrne G W; McClellan S; Nielsen D; Tone M; Waldmann H; Coffman T M; McCurry K R; Platt J L; Logan J S
In vivo transfer of GPI-linked complement restriction factors from erythrocytes to the endothelium.
Science (New York, N.Y.) 1995;269(5220):89-92.
-
1995: Watson C J; Davies H F; Cobbold S P; Rasmussen A; Rebello P R; Thiru S; Waldmann H; Calne R Y; Metcalfe S M
CD4 and CD8 monoclonal antibody therapy in the dog: strategies to induce tolerance to renal allografts.
Transplantation proceedings 1995;27(1):123-4.
-
1995: Brons I G; Davies H F; Rasmussen A; Watson C J; Thiru S; Cobbold S P; Waldmann H; Calne R Y
Islet allografting in the dog model: potential therapies for tolerance induction.
Transplantation proceedings 1995;27(1):609-10.
-
1995: Newman D K; Isaacs J D; Watson P G; Meyer P A; Hale G; Waldmann H
Prevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1H.
Eye (London, England) 1995;9 ( Pt 5)():564-9.
-
1994: Scully R; Qin S; Cobbold S; Waldmann H
Mechanisms in CD4 antibody-mediated transplantation tolerance: kinetics of induction, antigen dependency and role of regulatory T cells.
European journal of immunology 1994;24(10):2383-92.
-
1994: Waldmann H; Cobbold S; Hale G
What can be done to prevent graft versus host disease?
Current opinion in immunology 1994;6(5):777-83.
-
1994: Greenwood J; Gorman S D; Routledge E G; Lloyd I S; Waldmann H
Engineering multiple-domain forms of the therapeutic antibody CAMPATH-1H: effects on complement lysis.
Therapeutic immunology 1994;1(5):247-55.
-
1994: Chen Z; Cobbold S; Waldmann H; Metcalfe S
Combined use of RS61443 with CD4 and CD8 MAbs to generate tolerance to skin xenografts from rat to mouse.
Transplantation proceedings 1994;26(4):2433-4.
-
1994: Davies H S; Cobbold S P; Watson C J; Metcalfe S M; Rebello P R; Thiru S; McNair R; Rasmussen A; Waldmann H; Calne R Y
Production, selection, and testing of monoclonal antibodies to canine leukocytes in the dog kidney allograft model.
Transplantation proceedings 1994;26(4):1941-2.
-
1994: Moreau T; Thorpe J; Miller D; Moseley I; Hale G; Waldmann H; Clayton D; Wing M; Scolding N; Compston A
Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis.
Lancet 1994;344(8918):298-301.
-
1994: Chen Z; Cobbold S P; Waldmann H; Metcalfe S M
Tolerance induction in concordant heart-xenografted mice by CD4 and CD8 monoclonal antibodies.
Transplantation proceedings 1994;26(3):1199-200.
-
1994: Kooyman D; Byrne G; McClellan S; Nielsen D; Kagan D; Coffman T; Masahide T; Waldmann H; Platt J; Logan J
Erythroid-specific expression of human CD59 and transfer to vascular endothelial cells.
Transplantation proceedings 1994;26(3):1241.
-
1994: Diamond L E; Oldham E R; Platt J L; Waldmann H; Tone M; Walsh L A; Logan J S
Cell- and tissue-specific expression of a human CD59 minigene in transgenic mice.
Transplantation proceedings 1994;26(3):1239.
-
1994: Hale G; Waldmann H
Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases.
Bone marrow transplantation 1994;13(5):597-611.
-
1994: Brons I G; Davies H S; Makisalo H; Rasmussen A; Cobbold S P; Waldmann H; Calne R Y
Transplantation of immunomodulated dog islets.
Transplantation proceedings 1994;26(2):754.
-
1994: Gorman S D; Frewin M R; Cobbold S P; Waldmann H
Isolation and expression of cDNA encoding the canine CD4 and CD8 alpha antigens.
Tissue antigens 1994;43(3):184-8.
-
1994: Watson C J; Cobbold S P; Davies H S; Rebello P R; Thiru S; McNair R; Rasmussen A; Waldmann H; Calne R Y; Metcalfe S M
Immunosuppression of canine renal allograft recipients by CD4 and CD8 monoclonal antibodies.
Tissue antigens 1994;43(3):155-62.
-
1994: Watson C J; Cobbold S P; Davies H F; Rebello P R; Waldmann H; Calne R Y; Metcalfe S M
CD4 and CD8 monoclonal antibody therapy in canine renal allografts.
Transplant international : official journal of the European Society for Organ Transplantation 1994;7 Suppl 1():S322-4.
-
1994: Hale G; Waldmann H
CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
Journal of hematotherapy 1994;3(1):15-31.
-
1993: Parish N M; Hutchings P R; Waldmann H; Cooke A
Tolerance to IDDM induced by CD4 antibodies in nonobese diabetic mice is reversed by cyclophosphamide.
Diabetes 1993;42(11):1601-5.
-
1993: Watson C J; Cobbold S P; Davies H S; Rebello P R; Waldmann H; Calne R Y; Metcalfe S M
CD4 and CD8 monoclonal antibody therapy: strategies to prolong renal allograft survival in the dog.
The British journal of surgery 1993;80(11):1389-92.
-
1993: Waldmann H; Cobbold S
Monoclonal antibodies for the induction of transplantation tolerance.
Current opinion in immunology 1993;5(5):753-8.
-
1993: Xia M Q; Hale G; Waldmann H
Efficient complement-mediated lysis of cells containing the CAMPATH-1 (CDw52) antigen.
Molecular immunology 1993;30(12):1089-96.
-
1993: Xia M Q; Hale G; Lifely M R; Ferguson M A; Campbell D; Packman L; Waldmann H
Structure of the CAMPATH-1 antigen, a glycosylphosphatidylinositol-anchored glycoprotein which is an exceptionally good target for complement lysis.
The Biochemical journal 1993;293 ( Pt 3)():633-40.
-
1993: Lockwood C M; Thiru S; Isaacs J D; Hale G; Waldmann H
Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy.
Lancet 1993;341(8861):1620-2.
-
1993: Greenwood J; Clark M; Waldmann H
Structural motifs involved in human IgG antibody effector functions.
European journal of immunology 1993;23(5):1098-104.
-
1993: Watts R A; Isaacs J D; Hale G; Hazleman B L; Waldmann H
CAMPATH-1H in inflammatory arthritis.
Clinical and experimental rheumatology 1993;11 Suppl 8():S165-7.
-
1993: Waldmann H; Cobbold S P; Isaacs J; Hale G; Hazleman B; Cooke A; Lockwood M
Reprogramming the immune system: a possible therapeutic approach to established autoimmune disease.
Clinical and experimental rheumatology 1993;11 Suppl 8():S137.
-
1993: Watson C J; Davies H S; Metcalfe S M; Cobbold S P; Rebello P R; Collier D S; Waldmann H; Calne R Y
CD4 monoclonal antibodies in the preclinical dog renal allograft model.
Transplantation proceedings 1993;25(1 Pt 1):804-6.
-
1993: Chen Z; Cobbold S; Waldmann H; Metcalfe S
Stability of tolerance in mice generated by CD4 and CD8 monoclonal antibody treatment: cell transfer experiments.
Transplantation proceedings 1993;25(1 Pt 1):790-1.
-
1993: Bolt S; Routledge E; Lloyd I; Chatenoud L; Pope H; Gorman S D; Clark M; Waldmann H
The generation of a humanized, non-mitogenic CD3 monoclonal antibody which retains in vitro immunosuppressive properties.
European journal of immunology 1993;23(2):403-11.
-
1993: Qin S; Cobbold S P; Pope H; Elliott J; Kioussis D; Davies J; Waldmann H
"Infectious" transplantation tolerance.
Science (New York, N.Y.) 1993;259(5097):974-7.
-
1993: Waldmann H; Qin S; Cobbold S P
Monoclonal antibodies for the therapeutic induction of tolerance.
Immunology series 1993;59():85-99.
-
1992: Waldmann H; Cobbold S P; Wraith D; Isaacs J
Therapeutic immunosuppression of T cells.
Current opinion in biotechnology 1992;3(6):668-74.
-
1992: Leong L Y; Qin S; Cobbold S P; Waldmann H
Classical transplantation tolerance in the adult: the interaction between myeloablation and immunosuppression.
European journal of immunology 1992;22(11):2825-30.
-
1992: Walsh L A; Tone M; Thiru S; Waldmann H
The CD59 antigen--a multifunctional molecule.
Tissue antigens 1992;40(5):213-20.
-
1992: Cobbold S P; Qin S; Leong L Y; Martin G; Waldmann H
Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies.
Immunological reviews 1992;129():165-201.
-
1992: Tone M; Walsh L A; Waldmann H
Gene structure of human CD59 and demonstration that discrete mRNAs are generated by alternative polyadenylation.
Journal of molecular biology 1992;227(3):971-6.
-
1992: Isaacs J D; Watts R A; Hazleman B L; Hale G; Keogan M T; Cobbold S P; Waldmann H
Humanised monoclonal antibody therapy for rheumatoid arthritis.
Lancet 1992;340(8822):748-52.
-
1992: Hutchings P; O'Reilly L; Parish N M; Waldmann H; Cooke A
The use of a non-depleting anti-CD4 monoclonal antibody to re-establish tolerance to beta cells in NOD mice.
European journal of immunology 1992;22(7):1913-8.
-
1992: Brons I G; Tavora P F; Cobbold S P; Davies H S; Waldmann H; Calne R Y
Synergistic monoclonal antibodies for in vitro immunomodulation of dog islets.
Transplantation proceedings 1992;24(3):1032-3.
-
1992: Isaacs J D; Clark M R; Greenwood J; Waldmann H
Therapy with monoclonal antibodies. An in vivo model for the assessment of therapeutic potential.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(10):3062-71.
-
1992: Chen Z; Cobbold S; Metcalfe S; Waldmann H
Tolerance in the mouse to major histocompatibility complex-mismatched heart allografts, and to rat heart xenografts, using monoclonal antibodies to CD4 and CD8.
European journal of immunology 1992;22(3):805-10.
-
1992: Brons I G; Champeney R; Cobbold S P; Davies H S; Waldmann H; Calne R Y
Immunomodulation of dog islets using a cocktail of monoclonal antibodies.
Transplant international : official journal of the European Society for Organ Transplantation 1992;5 Suppl 1():S484-6.
-
1991: Routledge E G; Lloyd I; Gorman S D; Clark M; Waldmann H
A humanized monovalent CD3 antibody which can activate homologous complement.
European journal of immunology 1991;21(11):2717-25.
-
1991: Friend P J; Waldmann H; Hale G; Cobbold S; Rebello P; Thiru S; Jamieson N V; Johnston P S; Calne R Y
Reversal of allograft rejection using the monoclonal antibody, Campath-1G.
Transplantation proceedings 1991;23(4):2253-4.
-
1991: Xia M Q; Tone M; Packman L; Hale G; Waldmann H
Characterization of the CAMPATH-1 (CDw52) antigen: biochemical analysis and cDNA cloning reveal an unusually small peptide backbone.
European journal of immunology 1991;21(7):1677-84.
-
1991: Gorman S D; Clark M R; Routledge E G; Cobbold S P; Waldmann H
Reshaping a therapeutic CD4 antibody.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(10):4181-5.
-
1991: Walsh L A; Tone M; Waldmann H
Transfection of human CD59 complementary DNA into rat cells confers resistance to human complement.
European journal of immunology 1991;21(3):847-50.
-
1991: Friend P J; Waldmann H; Cobbold S; Tighe H; Rebello P; Wight D; Gore S; Pollard S; Lim S; Johnston P
The anti-IL-2 receptor monoclonal antibody YTH-906 in liver transplantation.
Transplantation proceedings 1991;23(1 Pt 2):1390-2.
-
1991: Varey A M; Hutchings P; O'Reilly L; Hussell T; Waldmann H; Simpson E; Cooke A
The development of insulin-dependent diabetes mellitus in non-obese diabetic mice: the role of CD4+ and CD8+ T cells.
Biochemical Society transactions 1991;19(1):187-91.
-
1990: Cobbold S P; Martin G; Waldmann H
The induction of skin graft tolerance in major histocompatibility complex-mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti-CD4 and anti-CD8 antibodies.
European journal of immunology 1990;20(12):2747-55.
-
1990: Qin S X; Wise M; Cobbold S P; Leong L; Kong Y C; Parnes J R; Waldmann H
Induction of tolerance in peripheral T cells with monoclonal antibodies.
European journal of immunology 1990;20(12):2737-45.
-
1990: Cobbold S P; Qin S X; Waldmann H
Reprogramming the immune system for tolerance with monoclonal antibodies.
Seminars in immunology 1990;2(6):377-87.
-
1990: Meri S; Morgan B P; Davies A; Daniels R H; Olavesen M G; Waldmann H; Lachmann P J
Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers.
Immunology 1990;71(1):1-9.
-
1990: Mathieson P W; Cobbold S P; Hale G; Clark M R; Oliveira D B; Lockwood C M; Waldmann H
Monoclonal-antibody therapy in systemic vasculitis.
The New England journal of medicine 1990;323(4):250-4.
-
1990: Hutchings P R; Simpson E; O'Reilly L A; Lund T; Waldmann H; Cooke A
The involvement of Ly2+ T cells in beta cell destruction.
Journal of autoimmunity 1990;3 Suppl 1():101-9.
-
1990: Hale G; Xia M Q; Tighe H P; Dyer M J; Waldmann H
The CAMPATH-1 antigen (CDw52).
Tissue antigens 1990;35(3):118-27.
-
1990: Bindon C I; Hale G; Waldmann H
Complement activation by immunoglobulin does not depend solely on C1q binding.
European journal of immunology 1990;20(2):277-81.
-
1990: Cobbold S P; Hale G; Clark M R; Waldmann H
Purging in auto- and allografts: monoclonal antibodies which use human complement and other natural effector mechanisms.
Progress in clinical and biological research 1990;333():139-51; discussion 152-4.
-
1989: Brüggemann M; Winter G; Waldmann H; Neuberger M S
The immunogenicity of chimeric antibodies.
The Journal of experimental medicine 1989;170(6):2153-7.
-
1989: Brüggemann M; Caskey H M; Teale C; Waldmann H; Williams G T; Surani M A; Neuberger M S
A repertoire of monoclonal antibodies with human heavy chains from transgenic mice.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(17):6709-13.
-
1989: Friend P J; Hale G; Waldmann H; Gore S; Thiru S; Joysey V; Evans D B; Calne R Y
Campath-1M--prophylactic use after kidney transplantation. A randomized controlled clinical trial.
Transplantation 1989;48(2):248-53.
-
1989: Dyer M J; Hale G; Hayhoe F G; Waldmann H
Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype.
Blood 1989;73(6):1431-9.
-
1989: Brüggemann M; Teale C; Clark M; Bindon C; Waldmann H
A matched set of rat/mouse chimeric antibodies. Identification and biological properties of rat H chain constant regions mu, gamma 1, gamma 2a, gamma 2b, gamma 2c, epsilon, and alpha.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(9):3145-50.
-
1989: Qin S X; Cobbold S; Benjamin R; Waldmann H
Induction of classical transplantation tolerance in the adult.
The Journal of experimental medicine 1989;169(3):779-94.
-
1989: Clark M; Bindon C; Dyer M; Friend P; Hale G; Cobbold S; Calne R; Waldmann H
The improved lytic function and in vivo efficacy of monovalent monoclonal CD3 antibodies.
European journal of immunology 1989;19(2):381-8.
-
1989: Zamoyska R; Waldmann H; Matzinger P
Peripheral tolerance mechanisms prevent the development of autoreactive T cells in chimeras grafted with two minor incompatible thymuses.
European journal of immunology 1989;19(1):111-7.
-
1989: Waldmann H; Cobbold S P; Qin S; Benjamin R J; Wise M
Tolerance induction in the adult using monoclonal antibodies to CD4, CD8, and CD11a (LFA-1).
Cold Spring Harbor symposia on quantitative biology 1989;54 Pt 2():885-92.
-
1989: Waldmann H
Manipulation of T-cell responses with monoclonal antibodies.
Annual review of immunology 1989;7():407-44.
-
1988: Waldmann H
Immunosuppression with monoclonal antibodies: some speculations about tolerance in the context of tissue grafting.
Transplantation proceedings 1988;20(6 Suppl 8):46-52.
-
1988: Hale G; Dyer M J; Clark M R; Phillips J M; Marcus R; Riechmann L; Winter G; Waldmann H
Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H.
Lancet 1988;2(8625):1394-9.
-
1988: Gilliland L K; Clark M R; Waldmann H
Universal bispecific antibody for targeting tumor cells for destruction by cytotoxic T cells.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(20):7719-23.
-
1988: Bindon C I; Hale G; Waldmann H
Importance of antigen specificity for complement-mediated lysis by monoclonal antibodies.
European journal of immunology 1988;18(10):1507-14.
-
1988: Bindon C I; Hale G; Brüggemann M; Waldmann H
Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q.
The Journal of experimental medicine 1988;168(1):127-42.
-
1988: Benjamin R J; Qin S X; Wise M P; Cobbold S P; Waldmann H
Mechanisms of monoclonal antibody-facilitated tolerance induction: a possible role for the CD4 (L3T4) and CD11a (LFA-1) molecules in self-non-self discrimination.
European journal of immunology 1988;18(7):1079-88.
-
1988: Hale G; Cobbold S; Waldmann H
T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation.
Transplantation 1988;45(4):753-9.
-
1988: Brüggemann M; Delmastro-Galfrè P; Waldmann H; Calabi F
Sequence of a rat immunoglobulin gamma 2c heavy chain constant region cDNA: extensive homology to mouse gamma 3.
European journal of immunology 1988;18(2):317-9.
-
1988: Tighe H; Friend P J; Collier S J; Decurtins M; Lim S; Cobbold S P; Thiru S; Calne R Y; Waldmann H
Delayed allograft rejection in primates treated with anti-IL-2 receptor monoclonal antibody Campath-6.
Transplantation 1988;45(1):226-8.
-
1988: Clark M; Gilliland L; Waldmann H
The potential of hybrid antibodies secreted by hybrid-hybridomas in tumour therapy.
International journal of cancer. Supplement = Journal international du cancer. Supplement 1988;2():15-7.
-
1987: Clark M R; Waldmann H
T-cell killing of target cells induced by hybrid antibodies: comparison of two bispecific monoclonal antibodies.
Journal of the National Cancer Institute 1987;79(6):1393-401.
-
1987: Tighe H; Clark M; Waldmann H
Blocking of cytotoxic T cell function by monoclonal antibodies against the CD45 antigen (T200/leukocyte-common antigen).
Transplantation 1987;44(6):818-23.
-
1987: Brüggemann M; Williams G T; Bindon C I; Clark M R; Walker M R; Jefferis R; Waldmann H; Neuberger M S
Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.
The Journal of experimental medicine 1987;166(5):1351-61.
-
1987: Hale G; Cobbold S P; Waldmann H; Easter G; Matejtschuk P; Coombs R R
Isolation of low-frequency class-switch variants from rat hybrid myelomas.
Journal of immunological methods 1987;103(1):59-67.
-
1987: Friend P J; Tighe H; Lim S; Collier D S; Decurtins M; Gilliland L K; Thiru S; Calne R; Waldmann H
The use of monoclonal antibodies against activated human T cells following renal allografting in the baboon.
Transplantation proceedings 1987;19(5):4317-8.
-
1987: Qin S; Cobbold S; Tighe H; Benjamin R; Waldmann H
CD4 monoclonal antibody pairs for immunosuppression and tolerance induction.
European journal of immunology 1987;17(8):1159-65.
-
1987: Bindon C I; Hale G; Hughes-Jones N; Gorick B; Waldmann H
Synergistic complement lysis by monoclonal antibodies to the human leukocyte common antigen requires both the classical and alternative pathways.
Molecular immunology 1987;24(6):587-94.
-
1987: Friend P J; Calne R Y; Hale G; Waldmann H; Evans D B; Rolles K; Thiru S; Gore S
Prophylactic use of an antilymphocyte monoclonal antibody following renal transplantation: a randomized controlled trial.
Transplantation proceedings 1987;19(1 Pt 3):1898-900.
-
1987: Waldmann H; Cobbold S; Qin S; Benjamin R; Nash T; Welsh J; Tarnesby G
Monoclonal antibodies for the depletion of specific subpopulations of lymphocytes.
Ciba Foundation symposium 1987;129():194-208.
-
1986: Hale G; Waldmann H; Friend P; Calne R
Pilot study of CAMPATH-1, a rat monoclonal antibody that fixes human complement, as an immunosuppressant in organ transplantation.
Transplantation 1986;42(3):308-11.
-
1986: Benjamin R J; Cobbold S P; Clark M R; Waldmann H
Tolerance to rat monoclonal antibodies. Implications for serotherapy.
The Journal of experimental medicine 1986;163(6):1539-52.
-
1984: Matzinger P; Zamoyska R; Waldmann H
Self tolerance is H-2-restricted.
Nature 1984;308(5961):738-41.
-
1983: Hoang T; Gilmore D; Metcalf D; Cobbold S; Watt S; Clark M; Furth M; Waldmann H
Separation of hemopoietic cells from adult mouse marrow by use of monoclonal antibodies.
Blood 1983;61(3):580-8.
Sign-in to see more